Niagen Bioscience (FRA:OCD1) Institutional Ownership: 21.97% (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:OCD1 Niagen Bioscience Inc FRA:OCD1
67 GF Score
Price €2.58
GF Value €3.98
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Niagen Bioscience Institutional Ownership?

Niagen Bioscience FRA:OCD1 67 Institutional Ownership is 21.97% as of Jul. 29, 2026. GuruFocus rates FRA:OCD1 with a GF Score™ of 67/100 and a GF Value™ of €3.98 (Possible Value Trap). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Niagen Bioscience's institutional ownership is 21.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Niagen Bioscience's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Niagen Bioscience's Float Percentage Of Total Shares Outstanding is 65.14%.

Niagen Bioscience Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Niagen Bioscience's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Niagen Bioscience Institutional Ownership Chart

Niagen Bioscience Historical Data

The historical data trend for Niagen Bioscience can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 25.37 24.01 24.44 22.23 23.47 23.42 22.88 22.18 21.64 21.97
FRA:OCD1
67GF Score
Niagen Bioscience Inc FRA:OCD1
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Niagen Bioscience Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 21.97% mean?
Niagen Bioscience (FRA:OCD1) has a Institutional Ownership of 21.97% as of Jul. 29, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Niagen Bioscience and its competitors.
Is Niagen Bioscience's Institutional Ownership too high?
Niagen Bioscience's current Institutional Ownership is 21.97%. Overall, Niagen Bioscience has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Niagen Bioscience's Institutional Ownership compare to LCTX and IFRX?
Niagen Bioscience's Institutional Ownership of 21.97% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Niagen Bioscience and its competitors. Niagen Bioscience's current Institutional Ownership is 21.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Niagen Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Niagen Bioscience (FRA:OCD1) is currently considered Possible Value Trap. The stock's GF Value™ is €3.98, compared to a current price of €2.58 — trading 35.2% below its estimated fair value. The current Institutional Ownership is 21.97%. Niagen Bioscience's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Niagen Bioscience (FRA:OCD1), the current Institutional Ownership is 21.97% as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Niagen Bioscience (FRA:OCD1) Overvalued in 2026?

Based on GuruFocus' analysis, Niagen Bioscience stock appears to be undervalued. The current stock price of €2.58 is trading 35.2% below its estimated GF Value™ of €3.98. GuruFocus considers Niagen Bioscience to be Possible Value Trap.

Key valuation signals for FRA:OCD1:

  • Institutional Ownership: 21.97%
  • GF Value™: €3.98 vs. price of €2.58 (35.2% below fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the FRA:OCD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Niagen Bioscience Business Description

Other Exchanges NAGE:USAOCD1:Germany
Address 10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
67GF Score

Get the complete analysis for FRA:OCD1

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.58
Price
€3.98
GF Value